Ernexa Therapeutics Inc. - 8-K Filing
Sandra Gurrola, Senior Vice President of Finance at Ernexa Therapeutics Inc., resigned effective July 3, 2026. Her departure was not due to any disagreements with the company and she will provide part-time transition assistance through June's quarterly report filing. The company is searching for a successor and may use outside support in the interim. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 9.01 Financial Statements and Exhibits)
Tickers: $ERNA